A method for monitoring a patient&rsquos response to treatment of an eye disorder where the patient has been treated with ranibizumab, bevacizumab or aflibercept is disclosed. The patient&rsquos response to treatment is monitored remotely by the physician using a remote device that is able to carry out a sight test and supply the results to the physician and the results indicate alteration to the patient&rsquos treatment regime such that visual function is maintained above a threshold level.